Literature DB >> 30591568

Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.

Han Wang1, Jianxun Qi2, Shuijun Zhang2, Yan Li2, Shuguang Tan3, George F Gao4,2.   

Abstract

Natural killer (NK) cells are important component of innate immunity and also contribute to activating and reshaping the adaptive immune responses. The functions of NK cells are modulated by multiple inhibitory and stimulatory receptors. Among these receptors, the activating receptor CD226 (DNAM-1) mediates NK cell activation via binding to its nectin-like (Necl) family ligand, CD155 (Necl-5). Here, we present a unique side-by-side arrangement pattern of two tandem immunoglobulin V-set (IgV) domains deriving from the ectodomains of both human CD226 (hCD226-ecto) and mouse CD226 (mCD226-ecto), which is substantially different from the conventional head-to-tail arrangement of other multiple Ig-like domain molecules. The hybrid complex structure of mCD226-ecto binding to the first domain of human CD155 (hCD155-D1) reveals a conserved binding interface with the first domain of CD226 (D1), whereas the second domain of CD226 (D2) both provides structural supports for the unique architecture of CD226 and forms direct interactions with CD155. In the absence of the D2 domain, CD226-D1 exhibited substantially reduced binding efficacy to CD155. Collectively, these findings would broaden our knowledge of the interaction between NK cell receptors and the nectin/Necl family ligands, as well as provide molecular basis for the development of CD226-targeted antitumor immunotherapeutics.

Entities:  

Keywords:  DNAM-1; NK cell receptor; Necl-5; complex structure

Mesh:

Substances:

Year:  2018        PMID: 30591568      PMCID: PMC6338850          DOI: 10.1073/pnas.1815716116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  ARP/wARP and molecular replacement.

Authors:  A Perrakis; M Harkiolaki; K S Wilson; V S Lamzin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-09-21

2.  CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells.

Authors:  Hiroshi Kojima; Hirotaka Kanada; Seiichi Shimizu; Emi Kasama; Kazuko Shibuya; Hiromitsu Nakauchi; Toshiro Nagasawa; Akira Shibuya
Journal:  J Biol Chem       Date:  2003-07-07       Impact factor: 5.157

3.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

4.  Natural killer cell recognition of missing self.

Authors:  Klas Kärre
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 5.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

6.  Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).

Authors:  Felix A Deuss; Benjamin S Gully; Jamie Rossjohn; Richard Berry
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

7.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

8.  The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.

Authors:  Xin Yu; Kristin Harden; Lino C Gonzalez; Michelle Francesco; Eugene Chiang; Bryan Irving; Irene Tom; Sinisa Ivelja; Canio J Refino; Hilary Clark; Dan Eaton; Jane L Grogan
Journal:  Nat Immunol       Date:  2008-11-16       Impact factor: 25.606

9.  Accelerated tumor growth in mice deficient in DNAM-1 receptor.

Authors:  Akiko Iguchi-Manaka; Hirayasu Kai; Yumi Yamashita; Kai Shibata; Satoko Tahara-Hanaoka; Shin-ichiro Honda; Teruhito Yasui; Hitoshi Kikutani; Kazuko Shibuya; Akira Shibuya
Journal:  J Exp Med       Date:  2008-11-24       Impact factor: 14.307

Review 10.  Controlling natural killer cell responses: integration of signals for activation and inhibition.

Authors:  Eric O Long; Hun Sik Kim; Dongfang Liu; Mary E Peterson; Sumati Rajagopalan
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

View more
  9 in total

1.  Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1.

Authors:  Felix A Deuss; Gabrielle M Watson; Katharine J Goodall; Isobel Leece; Sayantani Chatterjee; Zhihui Fu; Morten Thaysen-Andersen; Daniel M Andrews; Jamie Rossjohn; Richard Berry
Journal:  J Biol Chem       Date:  2019-06-28       Impact factor: 5.157

Review 2.  Advances in NK cell production.

Authors:  Fang Fang; Siqi Xie; Minhua Chen; Yutong Li; Jingjing Yue; Jie Ma; Xun Shu; Yongge He; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

3.  BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer.

Authors:  Mei Feng; Zhongen Wu; Yan Zhou; Zhuang Wei; Enming Tian; Shenglin Mei; Yuanyuan Zhu; Chenglong Liu; Fenglian He; Huiyu Li; Cao Xie; Joy Jin; Jibin Dong; Dehua Yang; Ker Yu; Junbin Qian; Diether Lambrechts; Ming-Wei Wang; Di Zhu
Journal:  Signal Transduct Target Ther       Date:  2021-08-20

4.  DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.

Authors:  Kazuki Sato; Yumi Yamashita-Kanemaru; Fumie Abe; Rikito Murata; Yuho Nakamura-Shinya; Kazumasa Kanemaru; Masafumi Muratani; André Veillette; Motohito Goto; Mamoru Ito; Akira Shibuya; Kazuko Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

5.  TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.

Authors:  Ralph Ja Maas; Janneke S Hoogstad-van Evert; Jolien Mr Van der Meer; Vera Mekers; Somayeh Rezaeifard; Alan J Korman; Paul Kjd de Jonge; Jeannette Cany; Rob Woestenenk; Nicolaas Pm Schaap; Leon F Massuger; Joop H Jansen; Willemijn Hobo; Harry Dolstra
Journal:  Oncoimmunology       Date:  2020-11-08       Impact factor: 8.110

Review 6.  TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.

Authors:  Jinah Yeo; Minkyung Ko; Dong-Hee Lee; Yoon Park; Hyung-Seung Jin
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-28

7.  Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome.

Authors:  Jang Hyuck Lee; Seung Soo Yoo; Mi Jeong Hong; Jin Eun Choi; Soyoun Kim; Hyo-Gyoung Kang; Sook Kyung Do; Ji Hyun Kim; Sun Ah Baek; Won Kee Lee; Jae Do Yoo; Sun Ha Choi; Yong Hoon Lee; Hyewon Seo; Jaehee Lee; Shin Yup Lee; Seung Ick Cha; Chang Ho Kim; Jae Yong Park
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

Review 8.  Emergence of the CD226 Axis in Cancer Immunotherapy.

Authors:  Michael Conner; Ken W Hance; Sapna Yadavilli; James Smothers; Jeremy D Waight
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

9.  Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.

Authors:  Fangkun Liu; Jing Huang; Yuanyuan Xiong; Shuwang Li; Zhixiong Liu
Journal:  Aging (Albany NY)       Date:  2019-08-04       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.